54 848 54 848 Pill - blue & yellow capsule/oblong, 19mm
Pill with imprint 54 848 54 848 is Blue & Yellow, Capsule/Oblong and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Hikma Pharmaceuticals PLC.
Mycophenolate mofetil is used in the treatment of Organ Transplant, Rejection Prophylaxis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 54 848 54 848
Mycophenolate Mofetil
- Imprint
- 54 848 54 848
- Strength
- 250 mg
- Color
- Blue & Yellow
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Hikma Pharmaceuticals PLC
- National Drug Code (NDC)
- 00054-0163
- Inactive Ingredients
-
croscarmellose sodium,
FD&C Blue No. 1,
gelatin,
magnesium stearate,
corn starch,
ferric oxide red,
titanium dioxide,
ferric oxide yellow,
FD&C Red No. 3,
povidone,
shellac,
ferrosoferric oxide,
isopropyl alcohol,
butyl alcohol,
propylene glycol,
ammonia
Note: Inactive ingredients may vary.
Related images for "54 848 54 848"
More about mycophenolate mofetil
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (59)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
- Mycophenolate mofetil oral/injection drug information
- Mycophenolate (Intravenous) (Advanced Reading)
- Mycophenolate mofetil (Advanced Reading)
- Mycophenolate Mofetil Tablets
- Mycophenolate Mofetil Capsules
Other brands
Professional resources
- Mycophenolate monograph
- Mycophenolate (FDA)
- Mycophenolate Mofetil (FDA)
- Mycophenolate Mofetil Injection (FDA)
- Mycophenolate Suspension (FDA)
- Mycophenolate Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
